India News: NEW DELHI: India's drugs regulator on Sunday approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously develo.
Keran again cut off; roads to dozens of other far-flung areas remain closed
Rahul Gandhi tests positive for COVID-19
Surge in covid cases: Hospitals asked to increase beds by 30 pc, stop surgeries for two weeks, schools closed in Bengal
Students, others returning to Kashmir amid rise in COVID-19 cases
Covid norms should change as virus spreads through air: DAK
Telangana imposes night curfew from 9 PM to 5 AM till May 1
Union Minister Jitendra Singh tests positive for Covid-19
US Coast Guard confirms 5 crew of Louisiana boat accident dead, search suspended
First module of Russia s new space station to be ready for launch in 2025 - Roscosmos
Covishield is ready for roll-out in the coming weeks , said Adar Poonawalla. (File photo)
New Delhi:
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country s drug regulator cleared its Covishield vaccine for emergency approval in India. Mr Poonawalla reiterated that the Covishield vaccine developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca - is safe and effective against coronavirus and added that the vaccine is ready to roll out in the coming weeks .
Mr Poonawalla, CEO of the Serum Institute, said to be the world s largest vaccine maker, had earlier said the majority of the first 50 million doses will go to India .
The Central Licensing Authority on Saturday granted permission to Hyderabad-based Bharat Biotech to manufacture Covaxin for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency .